A bioinformatics pipeline describes 390 putative, novel inhibitory receptors, to facilitate targeted therapeutic strategies for diverse immune cell types in cancer therapy.

PRNewswire Singapore October 5 A new cell therapy targeting CD7 on leukaemia cells gives a potentially effective treatment ...

Steven Mansoor, M.D., Ph.D., a physician–scientist at Oregon Health & Science University, and his research team made a ...

The black widow spider is one of the most feared spider species. Its venom is a cocktail of seven different toxins that ...

Purespring Therapeutics Ltd. has raised £80 million (US$104.6 million) in a series B, putting it on course to be the first to take a gene therapy for a kidney disease into the clinic. The money ...

Recent advances that have enabled the growth of tissue cultures into organoids and embryoids have heightened interest as to ...

Curve Therapeutics ("Curve" or the "Company"), a private biotechnology company pioneering a revolutionary intracellular screening platform addressing complex and ...

A research team from Kyushu University in Japan has recently discovered a calcium-based mechanism that plays a key role in ...

The Black Widow spider is well renowned for its distinctive hourglass shape and venomous bite. The Venom of the black widow ...

Vincerx Pharma announces early results for VIP943 and VIP236 in Phase 1 studies targeting hard-to-treat cancers, with ...

Endothelial cells are major participants in and regulators of inflammatory reactions. Resting endothelial cells prevent coagulation, control blood flow and passage of proteins from blood into ...

In a breakthrough for cancer research, Medgnosis has leveraged its state-of-the-art generative AI (GenAI) system to transform drug discovery. This GenAI targets both druggable and undruggable proteins ...